Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest Content
Archive
For authors
About
Podcasts
Search for this keyword
Advanced search
Close
More
Main menu
Latest Content
Archive
For authors
About
Podcasts
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 9, Issue 1
Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Treatments
Original research
Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment
Online download statistics by month:
Online download statistics by month: March 2023 to February 2024
Abstract
Full
Pdf
Feb 2023
17
17
1
Mar 2023
499
499
167
Apr 2023
197
196
54
May 2023
177
168
85
Jun 2023
259
258
79
Jul 2023
165
161
96
Aug 2023
126
118
47
Sep 2023
82
73
48
Oct 2023
132
124
48
Nov 2023
136
105
48
Dec 2023
105
78
39
Jan 2024
122
116
63
Feb 2024
92
88
51
Total
2109
2001
826
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?